Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis

Headaches are a common source of pain and suffering. The study's purpose was to assess beta-blockers efficacy in preventing migraine and tension-type headache. Cochrane Register of Controlled Trials; MEDLINE; EMBASE; ISI Web of Science, clinical trial registries, CNKI, Wanfang and CQVIP were se...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 14; no. 3; p. e0212785
Main Authors Jackson, Jeffrey L, Kuriyama, Akira, Kuwatsuka, Yachiyo, Nickoloff, Sarah, Storch, Derek, Jackson, Wilkins, Zhang, Zhi-Jiang, Hayashino, Yasuaki
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 20.03.2019
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Headaches are a common source of pain and suffering. The study's purpose was to assess beta-blockers efficacy in preventing migraine and tension-type headache. Cochrane Register of Controlled Trials; MEDLINE; EMBASE; ISI Web of Science, clinical trial registries, CNKI, Wanfang and CQVIP were searched through 21 August 2018, for randomized trials in which at least one comparison was a beta-blocker for the prevention of migraine or tension-type headache in adults. The primary outcome, headache frequency per month, was extracted in duplicate and pooled using random effects models. This study included 108 randomized controlled trials, 50 placebo-controlled and 58 comparative effectiveness trials. Compared to placebo, propranolol reduced episodic migraine headaches by 1.5 headaches/month at 8 weeks (95% CI: -2.3 to -0.65) and was more likely to reduce headaches by 50% (RR: 1.4, 95% CI: 1.1-1.7). Trial Sequential Analysis (TSA) found that these outcomes were unlikely to be due to a Type I error. A network analysis suggested that beta-blocker's benefit for episodic migraines may be a class effect. Trials comparing beta-blockers to other interventions were largely single, underpowered trials. Propranolol was comparable to other medications known to be effective including flunarizine, topiramate and valproate. For chronic migraine, propranolol was more likely to reduce headaches by at least 50% (RR: 2.0, 95% CI: 1.0-4.3). There was only one trial of beta-blockers for tension-type headache. There is high quality evidence that propranolol is better than placebo for episodic migraine headache. Other comparisons were underpowered, rated as low-quality based on only including single trials, making definitive conclusions about comparative effectiveness impossible. There were few trials examining beta-blocker effectiveness for chronic migraine or tension-type headache though there was limited evidence of benefit. Prospero (ID: CRD42017050335).
AbstractList Headaches are a common source of pain and suffering. The study's purpose was to assess beta-blockers efficacy in preventing migraine and tension-type headache. Cochrane Register of Controlled Trials; MEDLINE; EMBASE; ISI Web of Science, clinical trial registries, CNKI, Wanfang and CQVIP were searched through 21 August 2018, for randomized trials in which at least one comparison was a beta-blocker for the prevention of migraine or tension-type headache in adults. The primary outcome, headache frequency per month, was extracted in duplicate and pooled using random effects models. There is high quality evidence that propranolol is better than placebo for episodic migraine headache. Other comparisons were underpowered, rated as low-quality based on only including single trials, making definitive conclusions about comparative effectiveness impossible. There were few trials examining beta-blocker effectiveness for chronic migraine or tension-type headache though there was limited evidence of benefit.
Background Headaches are a common source of pain and suffering. The study's purpose was to assess beta-blockers efficacy in preventing migraine and tension-type headache. Methods Cochrane Register of Controlled Trials; MEDLINE; EMBASE; ISI Web of Science, clinical trial registries, CNKI, Wanfang and CQVIP were searched through 21 August 2018, for randomized trials in which at least one comparison was a beta-blocker for the prevention of migraine or tension-type headache in adults. The primary outcome, headache frequency per month, was extracted in duplicate and pooled using random effects models. Data synthesis This study included 108 randomized controlled trials, 50 placebo-controlled and 58 comparative effectiveness trials. Compared to placebo, propranolol reduced episodic migraine headaches by 1.5 headaches/month at 8 weeks (95% CI: -2.3 to -0.65) and was more likely to reduce headaches by 50% (RR: 1.4, 95% CI: 1.1-1.7). Trial Sequential Analysis (TSA) found that these outcomes were unlikely to be due to a Type I error. A network analysis suggested that beta-blocker's benefit for episodic migraines may be a class effect. Trials comparing beta-blockers to other interventions were largely single, underpowered trials. Propranolol was comparable to other medications known to be effective including flunarizine, topiramate and valproate. For chronic migraine, propranolol was more likely to reduce headaches by at least 50% (RR: 2.0, 95% CI: 1.0-4.3). There was only one trial of beta-blockers for tension-type headache. Conclusions There is high quality evidence that propranolol is better than placebo for episodic migraine headache. Other comparisons were underpowered, rated as low-quality based on only including single trials, making definitive conclusions about comparative effectiveness impossible. There were few trials examining beta-blocker effectiveness for chronic migraine or tension-type headache though there was limited evidence of benefit. Registration Prospero (ID: CRD42017050335).
BACKGROUNDHeadaches are a common source of pain and suffering. The study's purpose was to assess beta-blockers efficacy in preventing migraine and tension-type headache. METHODSCochrane Register of Controlled Trials; MEDLINE; EMBASE; ISI Web of Science, clinical trial registries, CNKI, Wanfang and CQVIP were searched through 21 August 2018, for randomized trials in which at least one comparison was a beta-blocker for the prevention of migraine or tension-type headache in adults. The primary outcome, headache frequency per month, was extracted in duplicate and pooled using random effects models. DATA SYNTHESISThis study included 108 randomized controlled trials, 50 placebo-controlled and 58 comparative effectiveness trials. Compared to placebo, propranolol reduced episodic migraine headaches by 1.5 headaches/month at 8 weeks (95% CI: -2.3 to -0.65) and was more likely to reduce headaches by 50% (RR: 1.4, 95% CI: 1.1-1.7). Trial Sequential Analysis (TSA) found that these outcomes were unlikely to be due to a Type I error. A network analysis suggested that beta-blocker's benefit for episodic migraines may be a class effect. Trials comparing beta-blockers to other interventions were largely single, underpowered trials. Propranolol was comparable to other medications known to be effective including flunarizine, topiramate and valproate. For chronic migraine, propranolol was more likely to reduce headaches by at least 50% (RR: 2.0, 95% CI: 1.0-4.3). There was only one trial of beta-blockers for tension-type headache. CONCLUSIONSThere is high quality evidence that propranolol is better than placebo for episodic migraine headache. Other comparisons were underpowered, rated as low-quality based on only including single trials, making definitive conclusions about comparative effectiveness impossible. There were few trials examining beta-blocker effectiveness for chronic migraine or tension-type headache though there was limited evidence of benefit. REGISTRATIONProspero (ID: CRD42017050335).
Background Headaches are a common source of pain and suffering. The study’s purpose was to assess beta-blockers efficacy in preventing migraine and tension-type headache. Methods Cochrane Register of Controlled Trials; MEDLINE; EMBASE; ISI Web of Science, clinical trial registries, CNKI, Wanfang and CQVIP were searched through 21 August 2018, for randomized trials in which at least one comparison was a beta-blocker for the prevention of migraine or tension-type headache in adults. The primary outcome, headache frequency per month, was extracted in duplicate and pooled using random effects models. Data synthesis This study included 108 randomized controlled trials, 50 placebo-controlled and 58 comparative effectiveness trials. Compared to placebo, propranolol reduced episodic migraine headaches by 1.5 headaches/month at 8 weeks (95% CI: -2.3 to -0.65) and was more likely to reduce headaches by 50% (RR: 1.4, 95% CI: 1.1–1.7). Trial Sequential Analysis (TSA) found that these outcomes were unlikely to be due to a Type I error. A network analysis suggested that beta-blocker’s benefit for episodic migraines may be a class effect. Trials comparing beta-blockers to other interventions were largely single, underpowered trials. Propranolol was comparable to other medications known to be effective including flunarizine, topiramate and valproate. For chronic migraine, propranolol was more likely to reduce headaches by at least 50% (RR: 2.0, 95% CI: 1.0–4.3). There was only one trial of beta-blockers for tension-type headache. Conclusions There is high quality evidence that propranolol is better than placebo for episodic migraine headache. Other comparisons were underpowered, rated as low-quality based on only including single trials, making definitive conclusions about comparative effectiveness impossible. There were few trials examining beta-blocker effectiveness for chronic migraine or tension-type headache though there was limited evidence of benefit. Registration Prospero (ID: CRD42017050335).
Headaches are a common source of pain and suffering. The study's purpose was to assess beta-blockers efficacy in preventing migraine and tension-type headache. Cochrane Register of Controlled Trials; MEDLINE; EMBASE; ISI Web of Science, clinical trial registries, CNKI, Wanfang and CQVIP were searched through 21 August 2018, for randomized trials in which at least one comparison was a beta-blocker for the prevention of migraine or tension-type headache in adults. The primary outcome, headache frequency per month, was extracted in duplicate and pooled using random effects models. This study included 108 randomized controlled trials, 50 placebo-controlled and 58 comparative effectiveness trials. Compared to placebo, propranolol reduced episodic migraine headaches by 1.5 headaches/month at 8 weeks (95% CI: -2.3 to -0.65) and was more likely to reduce headaches by 50% (RR: 1.4, 95% CI: 1.1-1.7). Trial Sequential Analysis (TSA) found that these outcomes were unlikely to be due to a Type I error. A network analysis suggested that beta-blocker's benefit for episodic migraines may be a class effect. Trials comparing beta-blockers to other interventions were largely single, underpowered trials. Propranolol was comparable to other medications known to be effective including flunarizine, topiramate and valproate. For chronic migraine, propranolol was more likely to reduce headaches by at least 50% (RR: 2.0, 95% CI: 1.0-4.3). There was only one trial of beta-blockers for tension-type headache. There is high quality evidence that propranolol is better than placebo for episodic migraine headache. Other comparisons were underpowered, rated as low-quality based on only including single trials, making definitive conclusions about comparative effectiveness impossible. There were few trials examining beta-blocker effectiveness for chronic migraine or tension-type headache though there was limited evidence of benefit. Prospero (ID: CRD42017050335).
Audience Academic
Author Kuwatsuka, Yachiyo
Nickoloff, Sarah
Zhang, Zhi-Jiang
Jackson, Wilkins
Jackson, Jeffrey L
Hayashino, Yasuaki
Kuriyama, Akira
Storch, Derek
AuthorAffiliation 5 Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan, China
Keele University, UNITED KINGDOM
2 Department of General Medicine, Kurashiki Central Hospital, Okayama, Japan
1 Department of Medicine, Zablocki VA Medical Center, Milwaukee, WI, United States of America
6 Department of Endocrinology, Tenri Hospital, Nara, Japan
4 Department of Biology, University of Wisconsin-Milwaukee, Milwaukee, WI, United States of America
3 Department of Medicine, Nagoya University Hospital, Nagoya, Japan
AuthorAffiliation_xml – name: 2 Department of General Medicine, Kurashiki Central Hospital, Okayama, Japan
– name: 4 Department of Biology, University of Wisconsin-Milwaukee, Milwaukee, WI, United States of America
– name: 6 Department of Endocrinology, Tenri Hospital, Nara, Japan
– name: 1 Department of Medicine, Zablocki VA Medical Center, Milwaukee, WI, United States of America
– name: 5 Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan, China
– name: Keele University, UNITED KINGDOM
– name: 3 Department of Medicine, Nagoya University Hospital, Nagoya, Japan
Author_xml – sequence: 1
  givenname: Jeffrey L
  orcidid: 0000-0002-9820-5834
  surname: Jackson
  fullname: Jackson, Jeffrey L
  organization: Department of Medicine, Zablocki VA Medical Center, Milwaukee, WI, United States of America
– sequence: 2
  givenname: Akira
  surname: Kuriyama
  fullname: Kuriyama, Akira
  organization: Department of General Medicine, Kurashiki Central Hospital, Okayama, Japan
– sequence: 3
  givenname: Yachiyo
  surname: Kuwatsuka
  fullname: Kuwatsuka, Yachiyo
  organization: Department of Medicine, Nagoya University Hospital, Nagoya, Japan
– sequence: 4
  givenname: Sarah
  surname: Nickoloff
  fullname: Nickoloff, Sarah
  organization: Department of Medicine, Zablocki VA Medical Center, Milwaukee, WI, United States of America
– sequence: 5
  givenname: Derek
  surname: Storch
  fullname: Storch, Derek
  organization: Department of Medicine, Zablocki VA Medical Center, Milwaukee, WI, United States of America
– sequence: 6
  givenname: Wilkins
  surname: Jackson
  fullname: Jackson, Wilkins
  organization: Department of Biology, University of Wisconsin-Milwaukee, Milwaukee, WI, United States of America
– sequence: 7
  givenname: Zhi-Jiang
  surname: Zhang
  fullname: Zhang, Zhi-Jiang
  organization: Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan, China
– sequence: 8
  givenname: Yasuaki
  surname: Hayashino
  fullname: Hayashino, Yasuaki
  organization: Department of Endocrinology, Tenri Hospital, Nara, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30893319$$D View this record in MEDLINE/PubMed
BookMark eNqNk22L1DAQx4uceA_6DUQLgijYtWmatHkjnIcPCwcHPr2TME0nu1nbZk3a0_32pm7v2Mq9kLxImPzmn5nJzGl01NkOo-gxSReEFuT1xg6ug2axDeZFmpGsKNm96IQImiU8S-nRwfk4OvV-k6aMlpw_iI5pWgpKiTiJvr_FHpKqseoHOh9r6-J-jfHW4TV2vbFdbHW8RqhBBbPpYqiHpvevYoj9zvfYQm9UHGiDv2Lo6rgd9SAEtvPGP4zua2g8Ppr2s-jr-3dfLj4ml1cflhfnl4kqWNknhYAiE6AIr4QSmdJM1JRRwXlZlbmgHEqgXOWCaV7UIfSKEERkRCNwYBU9i57udbeN9XKqjJcZEYzylPEsEMs9UVvYyK0zLbidtGDkX4N1KwkupNKgrLAChgpKzlSu8hoKTlBowammNUMWtN5Mrw1Vi7UKhXLQzETnN51Zy5W9ljzPOBEiCLyYBJz9OaDvZWu8wqaBDu2wjzvjghZpQJ_9g96d3UStICRgOm3Du2oUleesEDkr8nKkFndQYdXYGhXaSJtgnzm8nDkEpsff_QoG7-Xy86f_Z6--zdnnB2zorqZfe9sMY7_5OZjvQeWs9w71bZFJKscpuKmGHKdATlMQ3J4cftCt003b0z_u1QRT
CitedBy_id crossref_primary_10_1177_0333102420963844
crossref_primary_10_1007_s11094_023_02914_0
crossref_primary_10_1007_s15006_023_2884_1
crossref_primary_10_1177_03331024211047454
crossref_primary_10_1016_j_jpain_2024_03_010
crossref_primary_10_1136_dtb_2021_000031
crossref_primary_10_7759_cureus_29833
crossref_primary_10_2147_JPR_S273119
crossref_primary_10_1007_s11916_022_01006_0
crossref_primary_10_1016_j_neurol_2021_07_006
crossref_primary_10_1016_j_lpmfor_2022_10_022
crossref_primary_10_3390_ijms232012164
crossref_primary_10_1016_j_jddst_2020_102012
crossref_primary_10_1038_s41467_020_17002_0
crossref_primary_10_18621_eurj_1282037
crossref_primary_10_1111_papr_12902
crossref_primary_10_1007_s11606_021_07135_3
crossref_primary_10_4103_aian_aian_40_24
crossref_primary_10_3390_molecules29122938
crossref_primary_10_1016_j_neurol_2020_11_012
crossref_primary_10_3897_rrpharmacology_7_67463
crossref_primary_10_1080_14737175_2020_1787834
crossref_primary_10_1111_head_14008
crossref_primary_10_2217_fnl_2019_0029
crossref_primary_10_1038_s41582_021_00509_5
crossref_primary_10_30629_2658_7947_2024_29_2_17_23
crossref_primary_10_1055_s_0042_1758781
crossref_primary_10_36290_med_2024_013
crossref_primary_10_1016_j_pharmthera_2023_108523
crossref_primary_10_1097_FBP_0000000000000533
crossref_primary_10_1055_s_0042_1756441
crossref_primary_10_3390_audiolres13010002
crossref_primary_10_1007_s00482_022_00671_9
crossref_primary_10_1007_s12529_023_10241_7
crossref_primary_10_1080_14728214_2023_2207819
crossref_primary_10_1097_MD_0000000000029265
crossref_primary_10_3390_ijms25031694
crossref_primary_10_1016_j_msksp_2023_102806
crossref_primary_10_1111_head_14359
crossref_primary_10_1177_03331024241228605
crossref_primary_10_3390_ijerph19074156
crossref_primary_10_1016_j_bcp_2020_113895
crossref_primary_10_1212_CPJ_0000000000000769
crossref_primary_10_1186_s10194_024_01758_7
crossref_primary_10_1016_j_ncl_2022_05_005
crossref_primary_10_1097_MD_0000000000024083
crossref_primary_10_1016_j_bpa_2020_08_002
crossref_primary_10_1007_s00115_022_01403_1
crossref_primary_10_1097_BRS_0000000000004790
crossref_primary_10_3166_dea_2020_0121
crossref_primary_10_1007_s11916_023_01151_0
crossref_primary_10_1186_s10194_023_01594_1
crossref_primary_10_22159_ajpcr_2022_v15i6_44496
crossref_primary_10_1016_j_isci_2022_104390
Cites_doi 10.1111/j.1600-0404.1976.tb04342.x
10.1111/j.1526-4610.1983.hed2304188.x
10.1001/jama.295.6.676
10.1177/0333102410381145
10.1007/s11606-013-2433-1
10.1111/j.1526-4610.1991.hed3110650.x
10.1111/j.1600-0404.1984.tb07772.x
10.1111/j.1526-4610.1988.hed2809607.x
10.1111/j.1526-4610.1972.hed1201015.x
10.5694/j.1326-5377.1968.tb27464.x
10.1503/cmaj.081657
10.1177/0333102416678382
10.1111/j.1526-4610.1991.hed3105333.x
10.1046/j.1468-2982.2003.00546.x
10.1111/j.1526-4610.1975.hed1502129.x
10.1016/j.ctim.2005.04.004
10.1016/0895-4356(91)90147-2
10.1111/j.1600-0404.1986.tb07873.x
10.1046/j.1468-2982.1985.0503159.x
10.1016/0197-2456(86)90046-2
10.1046/j.1468-2982.1990.1002101.x
10.1111/j.1526-4610.2008.01263.x
10.1111/j.1526-4610.1990.hed3010639.x
10.1017/S0317167100041962
10.1212/WNL.0b013e3182535d20
10.1177/1536867X0900900103
10.1002/sim.1482
10.1111/j.1526-4610.1986.hed2604175.x
10.1111/j.1526-4610.1978.hed1801020.x
10.1111/j.1526-4610.1989.hed22904219.x
10.1007/s10654-004-6519-2
10.1007/s10072-013-1370-4
10.1111/j.1526-4610.1980.h2004006.x
10.1177/033310240102100708
10.1111/j.1526-4610.1987.hed2708421.x
10.1046/j.1468-2982.1989.904247.x
10.1007/s11606-014-3107-3
10.1111/j.1600-0404.1986.tb04591.x
10.1055/s-2008-1068322
10.1111/j.1526-4610.2007.00785.x
10.1001/jama.279.5.381
10.1111/j.1468-1331.2011.03612.x
10.1136/bmj.c5222
10.1046/j.1468-2982.1983.0304207.x
10.1046/j.1468-2982.1987.0704231.x
10.1097/00005650-198903001-00015
10.1046/j.1468-2982.2002.t01-1-00309.x
10.1046/j.1468-2982.1993.1302128.x
10.1111/j.1526-4610.1973.hed1204163.x
10.1111/j.1742-1241.1983.tb08456.x
10.1136/bmj.327.7414.557
10.1016/0002-8703(84)90600-8
10.1111/j.1526-4610.1987.hed2707372.x
10.1111/j.1526-4610.1981.hed2103105.x
10.1001/archinte.159.8.813
10.1007/BF00280110
10.1046/j.1468-2982.2001.00168.x
10.1111/j.1468-2982.2007.01377.x
10.1111/j.1526-4610.1979.hed1907379.x
10.1111/j.1600-0404.1986.tb03299.x
10.1016/0895-4356(92)90054-Q
10.1111/j.1468-2982.2004.00678.x
10.1111/j.1600-0404.1977.tb01423.x
10.1111/j.1600-0404.1983.tb04561.x
10.1111/j.1600-0404.1974.tb02810.x
10.1007/s10194-006-0273-7
10.1371/journal.pone.0130733
10.1002/sim.4780070807
10.1001/archneur.1997.00550210071015
10.1111/j.1600-0404.1980.tb01504.x
10.1111/j.1365-2524.1988.hed2801015.x
10.1111/j.1468-2982.2007.01288.x
10.1136/bmj.315.7109.629
10.1111/j.1526-4610.1985.hed2506320.x
10.1111/j.1600-0404.1984.tb00815.x
10.1177/0333102414552532
10.1111/j.1526-4610.2006.00598.x
10.1111/j.1526-4610.1989.hed22904215.x
10.1111/j.1526-4610.1985.hed2502107.x
10.1111/j.1600-0404.1983.tb04836.x
10.1177/03331024870070S6204
10.1111/j.1526-4610.1976.hed1605238.x
10.1046/j.1468-2982.1984.0402091.x
10.1111/j.1526-4610.2010.01770.x
10.1111/j.1600-0404.1994.tb02664.x
10.1136/bmj.2.5921.699
10.1046/j.1468-2982.1982.0203165.x
10.1111/j.1600-0404.1981.tb04407.x
10.1111/j.1526-4610.2008.01117_1.x
10.1212/WNL.0b013e31824d5846
10.1111/j.1468-2982.2009.01948.x
10.1111/j.1526-4610.1986.hed2610490.x
10.1177/03331024880080S805
10.1007/s11910-003-0060-7
10.1046/j.1468-2982.1996.1606441.x
10.1001/jama.1984.03350180030025
10.1590/S0004-282X2010000600008
10.1016/j.jclinepi.2007.03.013
10.1177/0333102415580099
10.1001/jama.2012.505
10.1177/03331024870070S6203
10.1111/j.1526-4610.2012.02223.x
10.1001/archneur.1993.00540080036010
10.1046/j.1468-2982.2003.00543.x
10.1371/journal.pmed.1000097
10.1016/0197-2456(95)00134-4
10.1016/j.clinthera.2007.05.008
10.1111/j.1600-0404.1972.tb07532.x
10.1046/j.1468-2982.1991.1101037.x
10.1111/j.1365-2796.1994.tb01102.x
10.1046/j.1468-2982.1985.0501017.x
10.1590/S0004-282X1997000400003
10.1136/jnnp.2005.073221
10.1212/WNL.51.5.1475
10.1177/0333102413515348
10.1046/j.1468-2982.1997.1705596.x
10.1177/0333102417738202
ContentType Journal Article
Copyright COPYRIGHT 2019 Public Library of Science
This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: COPYRIGHT 2019 Public Library of Science
– notice: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0212785
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Opposing Viewpoints (Gale)
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database (ProQuest)
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database (Proquest)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Database‎ (1962 - current)
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
Technology Collection
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
ProQuest Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agriculture Science Database
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
ProQuest Engineering Database
Nursing & Allied Health Premium
ProQuest Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
Access via ProQuest (Open Access)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Biological Science Collection
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
Technology Collection
Technology Research Database
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList


Agricultural Science Database
MEDLINE - Academic




MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
DocumentTitleAlternate Beta-blockers for preventing headaches
EISSN 1932-6203
Editor Kwok, Chun Shing
Editor_xml – sequence: 1
  givenname: Chun Shing
  surname: Kwok
  fullname: Kwok, Chun Shing
EndPage e0212785
ExternalDocumentID 2195360562
oai_doaj_org_article_beba5eca865c4c4da761e9f963f3d5e5
A579457482
10_1371_journal_pone_0212785
30893319
Genre Meta-Analysis
Systematic Review
Journal Article
GeographicLocations United States--US
Europe
Japan
GeographicLocations_xml – name: Europe
– name: United States--US
– name: Japan
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BBORY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CGR
CS3
CUY
CVF
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
ECM
EIF
EMOBN
ESTFP
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
NPM
O5R
O5S
OK1
P2P
P62
PATMY
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RIG
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
AAYXX
AFPKN
CITATION
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PQEST
PQUKI
PRINS
RC3
7X8
5PM
AAPBV
ABPTK
N95
ID FETCH-LOGICAL-c758t-79a729ac16b9c92cf59d3539668b84936a8a36c495f67d893b11eee51fea6a5b3
IEDL.DBID RPM
ISSN 1932-6203
IngestDate Sun Aug 06 00:15:53 EDT 2023
Tue Oct 22 15:13:20 EDT 2024
Tue Sep 17 21:21:00 EDT 2024
Fri Oct 25 22:28:11 EDT 2024
Thu Oct 10 19:29:47 EDT 2024
Thu Feb 22 23:57:58 EST 2024
Tue Nov 12 23:19:44 EST 2024
Thu Aug 01 20:36:49 EDT 2024
Thu Aug 01 19:20:44 EDT 2024
Tue Aug 20 22:11:42 EDT 2024
Wed Jul 17 12:59:25 EDT 2024
Wed Oct 16 00:46:16 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Creative Commons CC0 public domain
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c758t-79a729ac16b9c92cf59d3539668b84936a8a36c495f67d893b11eee51fea6a5b3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-9820-5834
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426199/
PMID 30893319
PQID 2195360562
PQPubID 1436336
PageCount e0212785
ParticipantIDs plos_journals_2195360562
doaj_primary_oai_doaj_org_article_beba5eca865c4c4da761e9f963f3d5e5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6426199
proquest_miscellaneous_2195269370
proquest_journals_2195360562
gale_infotracmisc_A579457482
gale_infotracacademiconefile_A579457482
gale_incontextgauss_ISR_A579457482
gale_incontextgauss_IOV_A579457482
gale_healthsolutions_A579457482
crossref_primary_10_1371_journal_pone_0212785
pubmed_primary_30893319
PublicationCentury 2000
PublicationDate 2019-03-20
PublicationDateYYYYMMDD 2019-03-20
PublicationDate_xml – month: 03
  year: 2019
  text: 2019-03-20
  day: 20
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2019
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References NJ Nambiar (ref117) 2011; 16
R DerSimonian (ref51) 1986; 7
B Holdorff (ref94) 1977; 72
J Wetterslev (ref54) 2008; 61
HC Diener (ref75) 2004; 251
RG Kaniecki (ref101) 1997; 54
KH Grotemeyer (ref90) 1990; 30
H Takaki (ref36) 2017; 9
SE Borgesen (ref68) 1974; 50
TE Wideroe (ref145) 1974; 2
N Abu Bakar (ref23) 2016; 36
T Pringsheim (ref29) 2010; 182
FG Freitag (ref83) 1984; 84
WD Gerber (ref86) 1995; 10
I White (ref56) 2009; 9
AM Agius (ref57) 2013; 51
J Hesse (ref93) 1994; 235
KA Holroyd (ref95) 2010; 341
Y Yang (ref157) 2016; 10
H Dongxiang (ref163) 2010; 31
SD Silberstein (ref34) 2012; 78
V Johannsson (ref96) 1987; 27
RH Johnson (ref97) 1986; 73
J Chen (ref148) 2009; 30
C Hedman (ref92) 1986; 74
SJ Wang (ref2) 2003; 3
KH Grotemeyer (ref89) 1988; 59
BK Rasmussen (ref20) 1991; 44
X Gong (ref150) 2016; 25
Z Li (ref161) 2002; 19
J Sargent (ref126) 1985; 25
LL van de Ven (ref142) 1997; 17
AM Adams (ref8) 2015; 35
D Follmann (ref48) 1992; 45
LJ Stovner (ref22) 2007; 27
R Kaushik (ref103) 2005; 13
W Kozubski (ref106) 1995; 29
GK Ahuja (ref58) 1985; 82
AR Jadad (ref46) 1996; 17
O Sjaastad (ref162) 1972; 48
N Karli (ref4) 2006; 7
CJ Shimell (ref128) 1990; 77
R Latinovic (ref24) 2006; 77
HK al-Qassab (ref59) 1993; 13
RB Domingues (ref76) 2009; 67
B Forssman (ref82) 1983; 23
RN Nanda (ref118) 1978; 18
D Moher (ref42) 2009; 6
J Zhu (ref160) 2005; 26
S Bonuso (ref66) 1998; 51
JW Lance (ref30) 1968; 1
G Knapp (ref55) 2003; 22
R Worz (ref146) 1992; 110
JN Mafi (ref38) 2015; 30
RB Weber (ref144) 1971; 21
A Falavigna (ref5) 2010; 68
PL Moja (ref31) 2005
JW Nadelmann (ref116) 1986; 26
AM Blumenfeld (ref10) 2011; 31
JL Jackson (ref28) 2012; 307
AC Lyngberg (ref19) 2005; 20
S Vilming (ref143) 1985; 5
RF Galbraith (ref49) 1988; 7
W Ma (ref154) 2011; 23
M Siniatchkin (ref130) 2007; 27
P Tfelt-Hansen (ref141) 1984; 69
B Kass (ref102) 1980; 61
Z Li (ref164) 2002; 19
R Formisano (ref80) 1991; 41
JD Carroll (ref70) 1990; 10
K Linde (ref40) 2004
BP Malvea (ref113) 1973; 12
K Ekbom (ref79) 1977; 56
RB Lipton (ref7) 2003; 23
P Kangasniemi (ref99) 1987; 7
SJ Tepper (ref13) 2008; 48
TA Shamliyan (ref41) 2013; 28
JP Higgins (ref50) 2003; 327
J Zhou (ref159) 2015; 14
CP Maissen (ref112) 1991; 121
CH Lucking (ref110) 1988; 8
HC Diener (ref72) 1996; 16
DK Ziegler (ref149) 1993; 50
WD Gerber (ref85) 1991; 11
P Louis (ref109) 1985; 5
A Pradalier (ref123) 1989; 9
A Baldrati (ref64) 1983; 67
PJ Kangasniemi (ref100) 1983; 68
P Stensrud (ref137) 1980; 20
PG Andersson (ref62) 1983; 3
A Raggi (ref12) 2010
LD Goldberg (ref16) 2005; 11
S Stellar (ref135) 1984; 252
P Li (ref152) 2006; 9
A Streng (ref139) 2006; 46
GW Albers (ref60) 1989; 29
KA Holroyd (ref39) 1991; 31
MJ Gawel (ref84) 1992; 19
NT Mathew (ref114) 1981; 21
(ref43) 2018; 38
K Ekbom (ref77) 1972; 12
A Kuritzky (ref107) 1987; 7
T Ferrante (ref18) 2013; 34
PS Sorensen (ref131) 1991; 31
AM Rapaport (ref33) 1994; 44
E Chronicle (ref26) 2004
RS Briggs (ref69) 1979; 19
Y Yang (ref156) 2006; 6
S Li (ref153) 2004; 25
RE Ryan Sr. (ref125) 1984; 108
HC Diener (ref74) 2002; 22
H Havanka-Kanniainen (ref91) 1988; 28
DC Buse (ref9) 2012; 52
B Mikkelsen (ref115) 1986; 73
D Ke (ref151) 2003; 15
K Ekbom (ref78) 1975; 15
D Soyka (ref132) 1990; 9
E Pita (ref122) 1977; 3
FG Freitag (ref14) 2007; 29
B Standnes (ref133) 1982; 2
MJ Kjaersgard Rasmussen (ref104) 1994; 89
PG Andersson (ref61) 1981; 64
CA Bordini (ref67) 1997; 55
JB Wen (ref155) 2016; 22
M Egger (ref53) 1997; 315
C Dahlof (ref71) 1987; 7
RE Ryan Sr. (ref124) 1982; 24
P Stensrud (ref136) 1976; 53
Z Hepp (ref37) 2017; 37
BK Rasmussen (ref1) 2001; 21
HP Ludin (ref111) 1989; 29
JL Jackson (ref32) 2010; 341
JL Jackson (ref17) 2015; 10
HD Langohr (ref108) 1985; 25
Q Yuan (ref158) 2005; 20
M Leonardi (ref11) 2010; 50
B Olerud (ref119) 1986; 26
R Schellenberg (ref127) 2008; 48
A Radtke (ref3) 2009; 49
RB Lipton (ref6) 2003; 23
KH Grotemeyer (ref88) 1987; 112
JA Klapper (ref105) 1994; 5
TG Palferman (ref121) 1983; 37
M Linde (ref25) 2012; 19
LJ Stovner (ref138) 2013; 34
F Ashtari (ref63) 2008; 118
A Sudilovsky (ref140) 1987; 27
SH Ghobadi (ref87) 2013; 8
SD Silberstein (ref129) 2012; 78
K Linde (ref27) 2004
HC Diener (ref73) 2001; 21
KG Nair (ref147) 1975; 21
XH Hu (ref15) 1999; 159
TJ Steiner (ref134) 1988; 28
PO Behan (ref65) 1980; 224
JL Peters (ref52) 2006; 295
B Forssman (ref81) 1976; 16
LE Kazis (ref47) 1989; 27
P Kangasniemi (ref98) 1984; 4
JPT Higgins (ref45) 2011
BS Schwartz (ref21) 1998; 279
JE Olsson (ref120) 1984; 70
A Ferrari (ref35) 2004; 24
L Bendtsen (ref44) 2010; 30
References_xml – volume: 251
  start-page: 943
  issue: 8
  year: 2004
  ident: ref75
  article-title: Topiramate in migraine prophylaxis—results from a placebo-controlled trial with propranolol as an active control
  publication-title: J Neurol
  contributor:
    fullname: HC Diener
– volume: 53
  start-page: 229
  issue: 3
  year: 1976
  ident: ref136
  article-title: Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1976.tb04342.x
  contributor:
    fullname: P Stensrud
– volume: 23
  start-page: 188
  issue: 4
  year: 1983
  ident: ref82
  article-title: Atenolol for migraine prophylaxis
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1983.hed2304188.x
  contributor:
    fullname: B Forssman
– volume: 295
  start-page: 676
  issue: 6
  year: 2006
  ident: ref52
  article-title: Comparison of two methods to detect publication bias in meta-analysis
  publication-title: JAMA
  doi: 10.1001/jama.295.6.676
  contributor:
    fullname: JL Peters
– volume: 31
  start-page: 301
  issue: 3
  year: 2011
  ident: ref10
  article-title: Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)
  publication-title: Cephalalgia
  doi: 10.1177/0333102410381145
  contributor:
    fullname: AM Blumenfeld
– volume: 28
  start-page: 1225
  issue: 9
  year: 2013
  ident: ref41
  article-title: Preventive pharmacologic treatments for episodic migraine in adults
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-013-2433-1
  contributor:
    fullname: TA Shamliyan
– volume: 118
  start-page: 301
  issue: 5
  year: 2008
  ident: ref63
  article-title: A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis
  publication-title: A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis
  contributor:
    fullname: F Ashtari
– volume: 31
  start-page: 650
  issue: 10
  year: 1991
  ident: ref131
  article-title: Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1991.hed3110650.x
  contributor:
    fullname: PS Sorensen
– volume: 69
  start-page: 1
  issue: 1
  year: 1984
  ident: ref141
  article-title: Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1984.tb07772.x
  contributor:
    fullname: P Tfelt-Hansen
– volume: 21
  start-page: 404
  year: 1971
  ident: ref144
  article-title: The treatment of migraine with propranolol
  publication-title: Neurology
  contributor:
    fullname: RB Weber
– start-page: CD003225
  issue: 2
  year: 2004
  ident: ref40
  article-title: Propranolol for migraine prophylaxis
  publication-title: Cochrane Database Syst Rev
  contributor:
    fullname: K Linde
– volume: 28
  start-page: 607
  issue: 9
  year: 1988
  ident: ref91
  article-title: Long acting propranolol in the prophylaxis of migraine. Comparison of the daily doses of 80 mg and 160 mg
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1988.hed2809607.x
  contributor:
    fullname: H Havanka-Kanniainen
– start-page: CD003225
  issue: 2
  year: 2004
  ident: ref27
  article-title: Propranolol for migraine prophylaxis
  publication-title: Cochrane Database Syst Rev
  contributor:
    fullname: K Linde
– volume: 12
  start-page: 15
  issue: 1
  year: 1972
  ident: ref77
  article-title: Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1972.hed1201015.x
  contributor:
    fullname: K Ekbom
– volume: 1
  start-page: 54
  issue: 2
  year: 1968
  ident: ref30
  article-title: Clinical trial of a new serotonin antagonist, BC105, in the prevention of migraine
  publication-title: Med J Aust
  doi: 10.5694/j.1326-5377.1968.tb27464.x
  contributor:
    fullname: JW Lance
– volume: 182
  start-page: E269
  issue: 7
  year: 2010
  ident: ref29
  article-title: Prophylaxis of migraine headache
  publication-title: CMAJ
  doi: 10.1503/cmaj.081657
  contributor:
    fullname: T Pringsheim
– volume: 37
  start-page: 470
  issue: 5
  year: 2017
  ident: ref37
  article-title: Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis
  publication-title: Cephalagia
  doi: 10.1177/0333102416678382
  contributor:
    fullname: Z Hepp
– volume: 31
  start-page: 333
  issue: 5
  year: 1991
  ident: ref39
  article-title: Propranolol in the management of recurrent migraine: a meta-analytic review
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1991.hed3105333.x
  contributor:
    fullname: KA Holroyd
– volume: 21
  start-page: 111
  issue: 3
  year: 1975
  ident: ref147
  article-title: A pilot study of the value of propranolol in migraine
  publication-title: J Postgrad Med
  contributor:
    fullname: KG Nair
– volume: 84
  start-page: 343
  issue: 4
  year: 1984
  ident: ref83
  article-title: Nadolol and placebo comparison study in the prophylactic treatment of migraine
  publication-title: J Am Osteopath Assoc
  contributor:
    fullname: FG Freitag
– volume: 23
  start-page: 441
  issue: 6
  year: 2003
  ident: ref7
  article-title: Migraine headache disability and health-related quality-of-life: a population-based case-control study from England
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2003.00546.x
  contributor:
    fullname: RB Lipton
– volume: 15
  start-page: 129
  issue: 2
  year: 1975
  ident: ref78
  article-title: Alprenolol for migraine prophylaxis
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1975.hed1502129.x
  contributor:
    fullname: K Ekbom
– volume: 13
  start-page: 165
  issue: 3
  year: 2005
  ident: ref103
  article-title: Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine
  publication-title: Complement Ther Med
  doi: 10.1016/j.ctim.2005.04.004
  contributor:
    fullname: R Kaushik
– volume: 44
  start-page: 1147
  issue: 11
  year: 1991
  ident: ref20
  article-title: Epidemiology of headache in a general population—A prevalence study
  publication-title: Journal of Clinical Epidemiology
  doi: 10.1016/0895-4356(91)90147-2
  contributor:
    fullname: BK Rasmussen
– volume: 74
  start-page: 475
  issue: 6
  year: 1986
  ident: ref92
  article-title: The difference between non-selective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1986.tb07873.x
  contributor:
    fullname: C Hedman
– volume: 5
  start-page: 159
  issue: 3
  year: 1985
  ident: ref109
  article-title: Metoprolol v. clonidine in the prophylactic treatment of migraine
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1985.0503159.x
  contributor:
    fullname: P Louis
– volume: 77
  start-page: 75
  issue: 2
  year: 1990
  ident: ref128
  article-title: A comparative trial of flunarizine and propranolol in the prevention of migraine
  publication-title: S Afr Med J
  contributor:
    fullname: CJ Shimell
– volume: 7
  start-page: 177
  issue: 3
  year: 1986
  ident: ref51
  article-title: Meta-analysis in clinical trials
  publication-title: Controlled Clinical Trials
  doi: 10.1016/0197-2456(86)90046-2
  contributor:
    fullname: R DerSimonian
– volume: 10
  start-page: 101
  issue: 2
  year: 1990
  ident: ref70
  article-title: Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1990.1002101.x
  contributor:
    fullname: JD Carroll
– volume: 49
  start-page: 79
  issue: 1
  year: 2009
  ident: ref3
  article-title: Prevalence and burden of headache and migraine in Germany
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2008.01263.x
  contributor:
    fullname: A Radtke
– volume: 30
  start-page: 639
  issue: 10
  year: 1990
  ident: ref90
  article-title: Acetylsalicylic acid vs. metoprolol in migraine prophylaxis—a double-blind cross-over study
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1990.hed3010639.x
  contributor:
    fullname: KH Grotemeyer
– volume: 19
  start-page: 340
  issue: 3
  year: 1992
  ident: ref84
  article-title: Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine
  publication-title: Can J Neurol Sci
  doi: 10.1017/S0317167100041962
  contributor:
    fullname: MJ Gawel
– volume: 78
  start-page: 1337
  issue: 17
  year: 2012
  ident: ref34
  article-title: Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3182535d20
  contributor:
    fullname: SD Silberstein
– volume: 5
  start-page: 50
  year: 1994
  ident: ref105
  article-title: An open label cross-over comparison of divalproex sodium and propranolol HCl in the prevention of migraine headaches
  publication-title: HEADACHE Q
  contributor:
    fullname: JA Klapper
– volume: 9
  start-page: 40
  year: 2009
  ident: ref56
  article-title: Multivariate random-effects meta-analysis
  publication-title: Stata Journal
  doi: 10.1177/1536867X0900900103
  contributor:
    fullname: I White
– volume: 22
  start-page: 2693
  issue: 17
  year: 2003
  ident: ref55
  article-title: Improved tests for a random effects meta-regression with a single covariate
  publication-title: Stat Med
  doi: 10.1002/sim.1482
  contributor:
    fullname: G Knapp
– volume: 26
  start-page: 175
  issue: 4
  year: 1986
  ident: ref116
  article-title: Propranolol in the prophylaxis of migraine
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1986.hed2604175.x
  contributor:
    fullname: JW Nadelmann
– volume: 18
  start-page: 20
  issue: 1
  year: 1978
  ident: ref118
  article-title: A double blind trial of acebutolol for migraine prophylaxis
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1978.hed1801020.x
  contributor:
    fullname: RN Nanda
– volume: 29
  start-page: 937
  issue: 6
  year: 1995
  ident: ref106
  article-title: Sodium valproate versus propranolol in the prophylactic treatment of migraine
  publication-title: Neurol Neurochir Pol
  contributor:
    fullname: W Kozubski
– volume: 19
  start-page: 419
  issue: 5
  year: 2002
  ident: ref164
  article-title: A clinical study of sibelium combining topiramate in prophylactic treatment of migraine
  publication-title: Chinese JMAP
  contributor:
    fullname: Z Li
– volume: 29
  start-page: 219
  issue: 4
  year: 1989
  ident: ref111
  article-title: Flunarizine and propranolol in the treatment of migraine
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1989.hed22904219.x
  contributor:
    fullname: HP Ludin
– volume: 20
  start-page: 243
  issue: 3
  year: 2005
  ident: ref19
  article-title: Has the prevalence of migraine and tension-type headache changed over a 12-year period
  publication-title: European Journal of Epidemiology
  doi: 10.1007/s10654-004-6519-2
  contributor:
    fullname: AC Lyngberg
– volume: 34
  start-page: S137
  issue: Suppl 1
  year: 2013
  ident: ref18
  article-title: Prevalence of tension-type headache in adult general population: the PACE study and review of the literature
  publication-title: Neurological Sciences
  doi: 10.1007/s10072-013-1370-4
  contributor:
    fullname: T Ferrante
– volume: 20
  start-page: 204
  issue: 4
  year: 1980
  ident: ref137
  article-title: Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1980.h2004006.x
  contributor:
    fullname: P Stensrud
– volume: 21
  start-page: 774
  issue: 7
  year: 2001
  ident: ref1
  article-title: Epidemiology of headache
  publication-title: Cephalalgia
  doi: 10.1177/033310240102100708
  contributor:
    fullname: BK Rasmussen
– volume: 27
  start-page: 421
  issue: 8
  year: 1987
  ident: ref140
  article-title: Comparative efficacy of nadolol and propranolol in the management of migraine
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1987.hed2708421.x
  contributor:
    fullname: A Sudilovsky
– volume: 10
  start-page: 109
  issue: 6
  year: 2016
  ident: ref157
  article-title: The effect of metoprolol combined with fluoxetine on preventing migraine and its effect on serotonin
  publication-title: Chinese Journal of Modern Drug Application
  contributor:
    fullname: Y Yang
– year: 2010
  ident: ref12
  article-title: Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life
  publication-title: Neurol Sci
  contributor:
    fullname: A Raggi
– volume: 9
  start-page: 247
  issue: 4
  year: 1989
  ident: ref123
  article-title: Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1989.904247.x
  contributor:
    fullname: A Pradalier
– volume: 30
  start-page: 548
  issue: 5
  year: 2015
  ident: ref38
  article-title: Trends in the ambulatory management of headache: analysis of NAMCS and NHAMCS data 1999–2010
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-014-3107-3
  contributor:
    fullname: JN Mafi
– volume: 73
  start-page: 490
  issue: 5
  year: 1986
  ident: ref97
  article-title: Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1986.tb04591.x
  contributor:
    fullname: RH Johnson
– volume: 112
  start-page: 1740
  issue: 45
  year: 1987
  ident: ref88
  article-title: Betablocker vs placebo in vasomotor headache. A double-blind crossover study
  publication-title: Dtsch Med Wochenschr
  doi: 10.1055/s-2008-1068322
  contributor:
    fullname: KH Grotemeyer
– volume: 48
  start-page: 118
  issue: 1
  year: 2008
  ident: ref127
  article-title: Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2007.00785.x
  contributor:
    fullname: R Schellenberg
– year: 2011
  ident: ref45
  article-title: Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2
  publication-title: Ref Type: Generic
  contributor:
    fullname: JPT Higgins
– volume: 10
  start-page: 27
  issue: 1
  year: 1995
  ident: ref86
  article-title: Cyclandelate versus propranolol in the prophylaxis of migraine—a double-blind placebo-controlled study
  publication-title: Funct Neurol
  contributor:
    fullname: WD Gerber
– volume: 279
  start-page: 381
  issue: 5
  year: 1998
  ident: ref21
  article-title: Epidemiology of tension-type headache
  publication-title: JAMA
  doi: 10.1001/jama.279.5.381
  contributor:
    fullname: BS Schwartz
– volume: 3
  start-page: 273
  issue: 3
  year: 1977
  ident: ref122
  article-title: Propranolol and migraine. A clinical trial
  publication-title: Arch Farmacol Toxicol
  contributor:
    fullname: E Pita
– volume: 20
  start-page: 182
  issue: 2
  year: 2005
  ident: ref158
  article-title: Preliminary randomized controlled trial of topiramate and propranolol to prevent migraine attacks
  publication-title: Huaxi Pharmaceutical Journal
  contributor:
    fullname: Q Yuan
– volume: 19
  start-page: 703
  issue: 5
  year: 2012
  ident: ref25
  article-title: The cost of headache disorders in Europe: the Eurolight project
  publication-title: European Journal of Neurology
  doi: 10.1111/j.1468-1331.2011.03612.x
  contributor:
    fullname: M Linde
– volume: 341
  start-page: c5222
  year: 2010
  ident: ref32
  article-title: Tricyclic antidepressants and headaches: systematic review and meta-analysis
  publication-title: BMJ
  doi: 10.1136/bmj.c5222
  contributor:
    fullname: JL Jackson
– volume: 341
  start-page: 769
  issue: 7776
  year: 2010
  ident: ref95
  article-title: Effect of preventive (Î2 blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: Randomised controlled trial
  contributor:
    fullname: KA Holroyd
– volume: 31
  start-page: 523
  issue: 5
  year: 2010
  ident: ref163
  article-title: Clinical trial of propranolol and amitriptyline in the treatment of migraine
  publication-title: Yunnan Medicine
  contributor:
    fullname: H Dongxiang
– volume: 3
  start-page: 207
  issue: 4
  year: 1983
  ident: ref62
  article-title: Prophylactic treatment of classical and non-classical migraine with metoprolol—a comparison with placebo
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1983.0304207.x
  contributor:
    fullname: PG Andersson
– volume: 9
  start-page: 62
  year: 2017
  ident: ref36
  article-title: Migraine-preventive prescription patters by specialty in ambulatory care settings in the United States
  publication-title: Prev Med
  contributor:
    fullname: H Takaki
– volume: 7
  start-page: 231
  issue: 4
  year: 1987
  ident: ref99
  article-title: Classic migraine: effective prophylaxis with metoprolol
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1987.0704231.x
  contributor:
    fullname: P Kangasniemi
– volume: 224
  start-page: 201
  issue: 1340
  year: 1980
  ident: ref65
  article-title: Propranolol in the treatment of migraine
  publication-title: Practitioner
  contributor:
    fullname: PO Behan
– volume: 27
  start-page: S178
  issue: Suppl 3
  year: 1989
  ident: ref47
  article-title: Effect sizes for interpreting changes in health status
  publication-title: Medical Care
  doi: 10.1097/00005650-198903001-00015
  contributor:
    fullname: LE Kazis
– volume: 22
  start-page: 209
  issue: 3
  year: 2002
  ident: ref74
  article-title: Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2002.t01-1-00309.x
  contributor:
    fullname: HC Diener
– volume: 19
  start-page: 419
  issue: 5
  year: 2002
  ident: ref161
  article-title: A clinical study of Sibelium combining Topiramate in prophylactic treatment of migraine
  publication-title: Chinese Journal of Primary Medicine and Pharmacy
  contributor:
    fullname: Z Li
– volume: 13
  start-page: 128
  issue: 2
  year: 1993
  ident: ref59
  article-title: Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1993.1302128.x
  contributor:
    fullname: HK al-Qassab
– volume: 12
  start-page: 163
  issue: 4
  year: 1973
  ident: ref113
  article-title: Propranolol prophylaxis of migraine
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1973.hed1204163.x
  contributor:
    fullname: BP Malvea
– volume: 37
  start-page: 28
  issue: 1
  year: 1983
  ident: ref121
  article-title: Prophylactic propranolol in the treatment of headache
  publication-title: Br J Clin Pract
  doi: 10.1111/j.1742-1241.1983.tb08456.x
  contributor:
    fullname: TG Palferman
– volume: 327
  start-page: 557
  issue: 7414
  year: 2003
  ident: ref50
  article-title: Measuring inconsistency in meta-analyses
  publication-title: BMJ
  doi: 10.1136/bmj.327.7414.557
  contributor:
    fullname: JP Higgins
– volume: 108
  start-page: 1156
  issue: 4
  year: 1984
  ident: ref125
  article-title: Comparative study of nadolol and propranolol in prophylactic treatment of migraine
  publication-title: Am Heart J
  doi: 10.1016/0002-8703(84)90600-8
  contributor:
    fullname: RE Ryan Sr.
– volume: 27
  start-page: 372
  issue: 7
  year: 1987
  ident: ref96
  article-title: Atenolol in migraine prophylaxis a double-blind cross-over multicentre study
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1987.hed2707372.x
  contributor:
    fullname: V Johannsson
– volume: 21
  start-page: 105
  issue: 3
  year: 1981
  ident: ref114
  article-title: Prophylaxis of migraine and mixed headache. A randomized controlled study
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1981.hed2103105.x
  contributor:
    fullname: NT Mathew
– volume: 15
  start-page: 760
  issue: 12
  year: 2003
  ident: ref151
  article-title: Sibiling combined with propranolol to treat migraine
  publication-title: Modern Practical Medicine
  contributor:
    fullname: D Ke
– volume: 159
  start-page: 813
  issue: 8
  year: 1999
  ident: ref15
  article-title: Burden of migraine in the United States: disability and economic costs
  publication-title: Archives of Internal Medicine
  doi: 10.1001/archinte.159.8.813
  contributor:
    fullname: XH Hu
– volume: 41
  start-page: 69
  issue: 1
  year: 1991
  ident: ref80
  article-title: Nimodipine in migraine: clinical efficacy and endocrinological effects
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/BF00280110
  contributor:
    fullname: R Formisano
– volume: 23
  start-page: 1275
  issue: 11
  year: 2011
  ident: ref154
  article-title: Therapeutic effect of metoprolol tartrate combined with flunarizine on migraine in the treatment of migraine
  publication-title: Modern Practical Medicine
  contributor:
    fullname: W Ma
– volume: 21
  start-page: 120
  issue: 2
  year: 2001
  ident: ref73
  article-title: A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2001.00168.x
  contributor:
    fullname: HC Diener
– volume: 27
  start-page: 1024
  issue: 9
  year: 2007
  ident: ref130
  article-title: Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study
  publication-title: Cephalalgia
  doi: 10.1111/j.1468-2982.2007.01377.x
  contributor:
    fullname: M Siniatchkin
– volume: 19
  start-page: 379
  year: 1979
  ident: ref69
  article-title: Timolol in migraine prophylaxis
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1979.hed1907379.x
  contributor:
    fullname: RS Briggs
– volume: 73
  start-page: 423
  issue: 4
  year: 1986
  ident: ref115
  article-title: Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1986.tb03299.x
  contributor:
    fullname: B Mikkelsen
– volume: 45
  start-page: 769
  issue: 7
  year: 1992
  ident: ref48
  article-title: Variance imputation for overviews of clinical trials with continuous response
  publication-title: Journal of Clinical Epidemiology
  doi: 10.1016/0895-4356(92)90054-Q
  contributor:
    fullname: D Follmann
– volume: 24
  start-page: 356
  issue: 5
  year: 2004
  ident: ref35
  article-title: Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study
  publication-title: Cephalalgia
  doi: 10.1111/j.1468-2982.2004.00678.x
  contributor:
    fullname: A Ferrari
– volume: 56
  start-page: 181
  issue: 2
  year: 1977
  ident: ref79
  article-title: Oxprenolol in the treatment of migraine
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1977.tb01423.x
  contributor:
    fullname: K Ekbom
– volume: 67
  start-page: 181
  issue: 3
  year: 1983
  ident: ref64
  article-title: Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1983.tb04561.x
  contributor:
    fullname: A Baldrati
– volume: 50
  start-page: 651
  issue: 5
  year: 1974
  ident: ref68
  article-title: Prophylactic treatment of migraine with propranolol. A clinical trial
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1974.tb02810.x
  contributor:
    fullname: SE Borgesen
– volume: 7
  start-page: 75
  issue: 2
  year: 2006
  ident: ref4
  article-title: Economic impact of primary headaches in Turkey: a university hospital based study: part II
  publication-title: J Headache Pain
  doi: 10.1007/s10194-006-0273-7
  contributor:
    fullname: N Karli
– volume: 72
  start-page: 1115
  issue: 25
  year: 1977
  ident: ref94
  article-title: Propranolol for prophylaxis of migraine
  publication-title: Medizinische Klinik
  contributor:
    fullname: B Holdorff
– volume: 10
  start-page: e0130733
  issue: 7
  year: 2015
  ident: ref17
  article-title: A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache
  publication-title: Plos One
  doi: 10.1371/journal.pone.0130733
  contributor:
    fullname: JL Jackson
– volume: 7
  start-page: 889
  issue: 8
  year: 1988
  ident: ref49
  article-title: A note on graphical presentation of estimated odds ratios from several clinical trials
  publication-title: Statistics in Medicine
  doi: 10.1002/sim.4780070807
  contributor:
    fullname: RF Galbraith
– volume: 54
  start-page: 1141
  issue: 9
  year: 1997
  ident: ref101
  article-title: A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1997.00550210071015
  contributor:
    fullname: RG Kaniecki
– volume: 61
  start-page: 351
  issue: 6
  year: 1980
  ident: ref102
  article-title: Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial.
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1980.tb01504.x
  contributor:
    fullname: B Kass
– volume: 8
  start-page: 144
  issue: 2
  year: 2013
  ident: ref87
  article-title: The prophylactic activity of propranol and nimodipineon migraine headache
  contributor:
    fullname: SH Ghobadi
– volume: 28
  start-page: 15
  issue: 1
  year: 1988
  ident: ref134
  article-title: Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up
  publication-title: Headache
  doi: 10.1111/j.1365-2524.1988.hed2801015.x
  contributor:
    fullname: TJ Steiner
– volume: 27
  start-page: 193
  issue: 3
  year: 2007
  ident: ref22
  article-title: The global burden of headache: a documentation of headache prevalence and disability worldwide
  publication-title: Cephalalgia
  doi: 10.1111/j.1468-2982.2007.01288.x
  contributor:
    fullname: LJ Stovner
– volume: 315
  start-page: 629
  issue: 7109
  year: 1997
  ident: ref53
  article-title: Bias in meta-analysis detected by a simple, graphical test
  publication-title: BMJ
  doi: 10.1136/bmj.315.7109.629
  contributor:
    fullname: M Egger
– volume: 25
  start-page: 320
  issue: 6
  year: 1985
  ident: ref126
  article-title: A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1985.hed2506320.x
  contributor:
    fullname: J Sargent
– volume: 70
  start-page: 160
  issue: 3
  year: 1984
  ident: ref120
  article-title: Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1984.tb00815.x
  contributor:
    fullname: JE Olsson
– volume: 25
  start-page: 416
  issue: 4
  year: 2004
  ident: ref153
  article-title: Therapeutic effect of sodium valproate on prevention of migraine recurrence
  publication-title: Sichuan Medical Journal
  contributor:
    fullname: S Li
– volume: 35
  start-page: 563
  issue: 7
  year: 2015
  ident: ref8
  article-title: The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results
  publication-title: Cephalalgia
  doi: 10.1177/0333102414552532
  contributor:
    fullname: AM Adams
– volume: 46
  start-page: 1492
  issue: 10
  year: 2006
  ident: ref139
  article-title: Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2006.00598.x
  contributor:
    fullname: A Streng
– volume: 29
  start-page: 215
  issue: 4
  year: 1989
  ident: ref60
  article-title: Nifedipine versus propranolol for the initial prophylaxis of migraine
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1989.hed22904215.x
  contributor:
    fullname: GW Albers
– volume: 25
  start-page: 107
  issue: 2
  year: 1985
  ident: ref108
  article-title: Clomipramine and metoprolol in migraine prophylaxis—a double-blind crossover study
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1985.hed2502107.x
  contributor:
    fullname: HD Langohr
– volume: 16
  start-page: 223
  issue: 3
  year: 2011
  ident: ref117
  article-title: Oral riboflavin versus oral propranolol in migraine prophylaxis: An open label randomized controlled trial
  contributor:
    fullname: NJ Nambiar
– volume: 68
  start-page: 262
  year: 1983
  ident: ref100
  article-title: Femoxetine—a new 5-HT uptake inhibitor—and propranolol in the prophylactic treatment of migraine
  publication-title: Acta neurologica Scandinavica
  doi: 10.1111/j.1600-0404.1983.tb04836.x
  contributor:
    fullname: PJ Kangasniemi
– volume: 7
  start-page: 459
  year: 1987
  ident: ref71
  article-title: No clearcut longterm prophylactic effect of one month of treatment with propranolol in migraineurs
  publication-title: Cephalalgia
  doi: 10.1177/03331024870070S6204
  contributor:
    fullname: C Dahlof
– volume: 16
  start-page: 238
  year: 1976
  ident: ref81
  article-title: Propranolol for migraine prophylaxis
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1976.hed1605238.x
  contributor:
    fullname: B Forssman
– volume: 4
  start-page: 91
  issue: 2
  year: 1984
  ident: ref98
  article-title: Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1984.0402091.x
  contributor:
    fullname: P Kangasniemi
– volume: 50
  start-page: 1576
  issue: 10
  year: 2010
  ident: ref11
  article-title: Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2010.01770.x
  contributor:
    fullname: M Leonardi
– volume: 89
  start-page: 446
  issue: 6
  year: 1994
  ident: ref104
  article-title: Tolfenamic acid versus propranolol in the prophylactic treatment of migraine
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1994.tb02664.x
  contributor:
    fullname: MJ Kjaersgard Rasmussen
– volume: 2
  start-page: 699
  issue: 5921
  year: 1974
  ident: ref145
  article-title: Propranolol in the treatment of migraine
  publication-title: Br Med J
  doi: 10.1136/bmj.2.5921.699
  contributor:
    fullname: TE Wideroe
– volume: 11
  start-page: S62
  issue: 2
  year: 2005
  ident: ref16
  article-title: The cost of migraine and its treatment
  publication-title: Am J Manag Care
  contributor:
    fullname: LD Goldberg
– volume: 30
  start-page: 119
  issue: 1
  year: 2009
  ident: ref148
  article-title: Clinical study of topiramate in preventing migraine attacks
  publication-title: Sichuan Medical Journal
  contributor:
    fullname: J Chen
– volume: 51
  start-page: 143
  issue: 2
  year: 2013
  ident: ref57
  article-title: A Randomized Controlled Trial comparing the efficacy of low-dose amitriptyline, amitriptyline with pindolol and surrogate placebo in the treatment of chronic tension-type facial pain
  publication-title: A Randomized Controlled Trial comparing the efficacy of low-dose amitriptyline, amitriptyline with pindolol and surrogate placebo in the treatment of chronic tension-type facial pain
  contributor:
    fullname: AM Agius
– volume: 110
  start-page: 268
  issue: 14
  year: 1992
  ident: ref146
  article-title: Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol
  publication-title: Fortschr Med
  contributor:
    fullname: R Worz
– volume: 2
  start-page: 165
  issue: 3
  year: 1982
  ident: ref133
  article-title: The prophylactic effect of timolol versus propranolol and placebo in common migraine: beta-blockers in migraine
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1982.0203165.x
  contributor:
    fullname: B Standnes
– volume: 64
  start-page: 280
  issue: 4
  year: 1981
  ident: ref61
  article-title: Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1981.tb04407.x
  contributor:
    fullname: PG Andersson
– volume: 9
  start-page: 45
  year: 1990
  ident: ref132
  article-title: Flunarizine versus propranolol in interval treatment of migraine
  publication-title: Nervenheilkunde
  contributor:
    fullname: D Soyka
– volume: 22
  start-page: 141
  issue: 6
  year: 2016
  ident: ref155
  article-title: Clinical effect analysis of sibelium prophylactic treatment of migraine
  publication-title: Contemporary Medicine
  contributor:
    fullname: JB Wen
– volume: 48
  start-page: 730
  issue: 5
  year: 2008
  ident: ref13
  article-title: A pivotal moment in 50 years of headache history: the first American Migraine Study
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2008.01117_1.x
  contributor:
    fullname: SJ Tepper
– volume: 78
  start-page: 976
  issue: 13
  year: 2012
  ident: ref129
  article-title: Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e31824d5846
  contributor:
    fullname: SD Silberstein
– volume: 25
  start-page: 24
  issue: 14
  year: 2016
  ident: ref150
  article-title: Therapeutic effect of metoprolol tartrate combined with flunarizine on migraine in the treatment of migraine
  publication-title: Journ of Integrative Medicine, Cardiovascular and Cerebrovascular Diseases
  contributor:
    fullname: X Gong
– volume: 30
  start-page: 1
  issue: 1
  year: 2010
  ident: ref44
  article-title: Guidelines for controlled trials of drugs in tension-type headache: Second edition
  publication-title: Cephalalgia
  doi: 10.1111/j.1468-2982.2009.01948.x
  contributor:
    fullname: L Bendtsen
– volume: 26
  start-page: 51
  issue: 1
  year: 2005
  ident: ref160
  article-title: Therapeutic effect of sibelium on migraine
  publication-title: Journal of Medical Forum
  contributor:
    fullname: J Zhu
– volume: 26
  start-page: 490
  issue: 10
  year: 1986
  ident: ref119
  article-title: Nadolol and propranolol in migraine management
  publication-title: Headache
  doi: 10.1111/j.1526-4610.1986.hed2610490.x
  contributor:
    fullname: B Olerud
– volume: 8
  start-page: 21
  issue: Suppl 8
  year: 1988
  ident: ref110
  article-title: Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients
  publication-title: Cephalalgia
  doi: 10.1177/03331024880080S805
  contributor:
    fullname: CH Lucking
– volume: 3
  start-page: 104
  issue: 2
  year: 2003
  ident: ref2
  article-title: Epidemiology of migraine and other types of headache in Asia
  publication-title: Current Neurology & Neuroscience Reports
  doi: 10.1007/s11910-003-0060-7
  contributor:
    fullname: SJ Wang
– volume: 16
  start-page: 441
  issue: 6
  year: 1996
  ident: ref72
  article-title: Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1996.1606441.x
  contributor:
    fullname: HC Diener
– volume: 252
  start-page: 2576
  issue: 18
  year: 1984
  ident: ref135
  article-title: Migraine prevention with timolol. A double-blind crossover study
  publication-title: JAMA
  doi: 10.1001/jama.1984.03350180030025
  contributor:
    fullname: S Stellar
– volume: 67
  start-page: 973
  issue: 4
  year: 2009
  ident: ref76
  article-title: A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine
  publication-title: A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine
  contributor:
    fullname: RB Domingues
– volume: 44
  start-page: S25
  issue: 5
  year: 1994
  ident: ref33
  article-title: Recurrent migraine: cost-effective care
  publication-title: Neurology
  contributor:
    fullname: AM Rapaport
– volume: 68
  start-page: 873
  issue: 6
  year: 2010
  ident: ref5
  article-title: Prevalence and impact of headache in undergraduate students in Southern Brazil
  publication-title: Arq Neuropsiquiatr
  doi: 10.1590/S0004-282X2010000600008
  contributor:
    fullname: A Falavigna
– volume: 61
  start-page: 64
  issue: 1
  year: 2008
  ident: ref54
  article-title: Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
  publication-title: J Clin Epidemiol
  doi: 10.1016/j.jclinepi.2007.03.013
  contributor:
    fullname: J Wetterslev
– volume: 36
  start-page: 67
  issue: 1
  year: 2016
  ident: ref23
  article-title: Quality of life in primary headache disorders: A review
  publication-title: Cephalalgia
  doi: 10.1177/0333102415580099
  contributor:
    fullname: N Abu Bakar
– volume: 307
  start-page: 1736
  issue: 16
  year: 2012
  ident: ref28
  article-title: Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis
  publication-title: JAMA
  doi: 10.1001/jama.2012.505
  contributor:
    fullname: JL Jackson
– volume: 6
  start-page: 4760
  issue: 24
  year: 2006
  ident: ref156
  article-title: Observation on the efficacy of propranolol in preventing menopausal migraine
  publication-title: Chinese Journal of Misdiagnosis
  contributor:
    fullname: Y Yang
– volume: 7
  start-page: 457
  year: 1987
  ident: ref107
  article-title: Prophylactic treatment of migraine with long acting propranolol—a comparison with placebo
  publication-title: Cephalalgia
  doi: 10.1177/03331024870070S6203
  contributor:
    fullname: A Kuritzky
– volume: 14
  start-page: 836
  issue: 10
  year: 2015
  ident: ref159
  article-title: The efficacy of metoprolol combined with fluoxetine in preventing migraine
  publication-title: Journal of Clinical and Experimental Medicine
  contributor:
    fullname: J Zhou
– volume: 52
  start-page: 1456
  issue: 10
  year: 2012
  ident: ref9
  article-title: Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study
  publication-title: Headache
  doi: 10.1111/j.1526-4610.2012.02223.x
  contributor:
    fullname: DC Buse
– volume: 82
  start-page: 263
  year: 1985
  ident: ref58
  article-title: Propranolol in prophylaxis of migraine
  publication-title: Indian J Med Res
  contributor:
    fullname: GK Ahuja
– volume: 50
  start-page: 825
  issue: 8
  year: 1993
  ident: ref149
  article-title: Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetic and therapeutic effects
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1993.00540080036010
  contributor:
    fullname: DK Ziegler
– start-page: CD002919
  issue: 3
  year: 2005
  ident: ref31
  article-title: Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches
  publication-title: Cochrane Database Syst Rev
  contributor:
    fullname: PL Moja
– volume: 59
  start-page: 549
  issue: 9
  year: 1988
  ident: ref89
  article-title: Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study
  publication-title: Nervenarzt
  contributor:
    fullname: KH Grotemeyer
– volume: 23
  start-page: 429
  issue: 6
  year: 2003
  ident: ref6
  article-title: The family impact of migraine: population-based studies in the USA and UK
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.2003.00543.x
  contributor:
    fullname: RB Lipton
– volume: 6
  start-page: e1000097
  issue: 7
  year: 2009
  ident: ref42
  article-title: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
  publication-title: PLOS Medicine
  doi: 10.1371/journal.pmed.1000097
  contributor:
    fullname: D Moher
– volume: 24
  start-page: 89
  issue: 2
  year: 1982
  ident: ref124
  article-title: Nadolol and placebo comparison study in the prophylactic treatment of migraine
  publication-title: Panminerva Med
  contributor:
    fullname: RE Ryan Sr.
– volume: 17
  start-page: 1
  issue: 1
  year: 1996
  ident: ref46
  article-title: Assessing the quality of reports of randomized clinical trials: is blinding necessary?
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(95)00134-4
  contributor:
    fullname: AR Jadad
– volume: 29
  start-page: 939
  issue: 5
  year: 2007
  ident: ref14
  article-title: The cycle of migraine: patients' quality of life during and between migraine attacks
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2007.05.008
  contributor:
    fullname: FG Freitag
– volume: 48
  start-page: 124
  issue: 1
  year: 1972
  ident: ref162
  article-title: Clinical trial of a beta-receptor blocking agent (LB 46) in migraine prophylaxis
  publication-title: Acta Neurol Scand
  doi: 10.1111/j.1600-0404.1972.tb07532.x
  contributor:
    fullname: O Sjaastad
– volume: 11
  start-page: 37
  issue: 1
  year: 1991
  ident: ref85
  article-title: Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1991.1101037.x
  contributor:
    fullname: WD Gerber
– volume: 235
  start-page: 451
  issue: 5
  year: 1994
  ident: ref93
  article-title: Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.1994.tb01102.x
  contributor:
    fullname: J Hesse
– volume: 5
  start-page: 17
  issue: 1
  year: 1985
  ident: ref143
  article-title: Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1985.0501017.x
  contributor:
    fullname: S Vilming
– volume: 55
  start-page: 536
  issue: 3B
  year: 1997
  ident: ref67
  article-title: Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial
  publication-title: Arq Neuropsiquiatr
  doi: 10.1590/S0004-282X1997000400003
  contributor:
    fullname: CA Bordini
– volume: 77
  start-page: 385
  issue: 3
  year: 2006
  ident: ref24
  article-title: Headache and migraine in primary care: consultation, prescription, and referral rates in a large population
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.2005.073221
  contributor:
    fullname: R Latinovic
– volume: 9
  start-page: 120
  issue: 5
  year: 2006
  ident: ref152
  article-title: Double-blind therapeutic effect of â-blockers on menopausal migraine
  publication-title: Chinese Journal of Practical Nervous Diseases
  contributor:
    fullname: P Li
– volume: 121
  start-page: 1585
  issue: 43
  year: 1991
  ident: ref112
  article-title: Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine
  publication-title: Schweiz Med Wochenschr
  contributor:
    fullname: CP Maissen
– issue: 3
  year: 2004
  ident: ref26
  article-title: Anticonvulsant drugs for migraine prophylaxis
  publication-title: Cochrane Library
  contributor:
    fullname: E Chronicle
– volume: 51
  start-page: 1475
  issue: 5
  year: 1998
  ident: ref66
  article-title: Long-term outcome of migraine therapy: predictive value of the frontotemporal nitroglycerin test
  publication-title: Neurology
  doi: 10.1212/WNL.51.5.1475
  contributor:
    fullname: S Bonuso
– volume: 34
  start-page: 523
  issue: 7
  year: 2013
  ident: ref138
  article-title: A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study
  publication-title: Cephalalgia
  doi: 10.1177/0333102413515348
  contributor:
    fullname: LJ Stovner
– volume: 17
  start-page: 596
  issue: 5
  year: 1997
  ident: ref142
  article-title: Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study
  publication-title: Cephalalgia
  doi: 10.1046/j.1468-2982.1997.1705596.x
  contributor:
    fullname: LL van de Ven
– volume: 38
  start-page: 1
  issue: 1
  year: 2018
  ident: ref43
  article-title: The International Classification of Headache Disorders, 3rd edition
  publication-title: Cephalalgia
  doi: 10.1177/0333102417738202
SSID ssj0053866
Score 2.5378323
SecondaryResourceType review_article
Snippet Headaches are a common source of pain and suffering. The study's purpose was to assess beta-blockers efficacy in preventing migraine and tension-type headache....
Background Headaches are a common source of pain and suffering. The study's purpose was to assess beta-blockers efficacy in preventing migraine and...
Background Headaches are a common source of pain and suffering. The study’s purpose was to assess beta-blockers efficacy in preventing migraine and...
BACKGROUNDHeadaches are a common source of pain and suffering. The study's purpose was to assess beta-blockers efficacy in preventing migraine and tension-type...
BackgroundHeadaches are a common source of pain and suffering. The study's purpose was to assess beta-blockers efficacy in preventing migraine and tension-type...
Background Headaches are a common source of pain and suffering. The study’s purpose was to assess beta-blockers efficacy in preventing migraine and...
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0212785
SubjectTerms Adrenergic beta-antagonists
Adrenergic beta-Antagonists - therapeutic use
Adult
Adults
Analysis
Antidepressants
Beta blockers
Clinical trials
Clinical Trials as Topic
Control methods
Dosage and administration
Error analysis
Female
Headache
Headaches
Hospitals
Humans
Male
Medicine
Medicine and Health Sciences
Meta-analysis
Migraine
Migraine Disorders - drug therapy
Migraine Disorders - physiopathology
Network analysis
Pain
Physical Sciences
Prevention
Propranolol
Propranolol - therapeutic use
Randomization
Research and Analysis Methods
Sequential analysis
Serotonin
Studies
Systematic review
Tension
Tension headache
Tension-Type Headache - drug therapy
Tension-Type Headache - physiopathology
Topiramate
Topiramate - therapeutic use
Treatment outcome
Valproic acid
Valproic Acid - therapeutic use
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLXQrNggyquBAgYhARJpEzt27GWLqAoSIAFF3SDLz1IByYjM_D_XsSdMUCVYsB3fRJn7sM9Jro8ResI0b30tbOkMd0BQmChFiLq3grQ8SMtoiC_0377jJ6fNmzN2tnXUV-wJS_LAyXEHxhvNvNWCM9vYxmng3V4GyJtAHfNJvbSSGzKV5mCoYs7zRjna1gc5LvvLvvP7o6h5PDt5ayEa9fqnWXmx_N4Pl0HOPzsnt5ai4-voWsaQ-DA9-w664rsbaCdX6YCfZSnp5zfRlyO_0qWBBesbwDwMABUD4MPLrNvUd7gPGKZjF2Wd8UWHRzmO4QXW-LfEM07bW7DuHP4R76ezkMktdHr86tPLkzIfqFBaoAWrspUasLS2NTfSSmIDk44yCoxHGNFIyrXQlFvgTIG3DpCMqWvvPauD11wzQ2-jRQcu3EWYVK72VTDEWaBoQmsurRFQz54YoHW0QOXGu2qZdDPU-PGsBb6R3KRiNFSORoGOYggm26h6Pf4AuaByLqi_5UKBHsYAqrSFdKpddchg1mFtI0iBHo8WUfmii60153o9DOr1-8__YPTxw8zoaTYKPaSC1Xk7A_ynqKg1s9ybWUL92tnwbky3jVcGReKXTR6BKVy5ScHLhx9Nw_GmsV2u8_062RAOyLMq0J2UsZNnaQWBhUAVqJ3l8sz185Hu4usoPM5Hvi3v_o9Y3UNXAXvK2M5Hqj20WP1c-_uA71bmwVjKvwCfZE_e
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9RAFB50BfFFbL00teooggqmzW0ueZJWXKtQBbXSlxLmWks1ic3u__ecZLJtpIivO2eH3XOb78yc-YaQ50xx4VJpYqu5hQKFyVh65L2VmeC-NCz3uKF_8InvHxYfj9hR2HDrQlvlmBP7RG0bg3vkOxme93Bcrt-0v2N8NQpPV8MTGtfJjTQTAosvOX8_ZmKIZc7DdblcpDvBOtttU7vtntocX1C-tBz1rP2r3DxrfzbdVcDz7_7JSwvS_A65HZAk3R1Mv0auuXqd3DwIZ-XrZC2EbUdfBm7pV3fJ8Z5bqFjDCnYGuI8CYqWAAGkbiJyamjaeQn62yPNMT2va83N0r6miF5zPdLjvQlVt6S-cTwVmk3vkcP7u29v9OLywEBuoExaxKBWAa2VSrktTZsaz0uYshxJIalmUOVdS5dxAEeW5sABtdJo651jqneKK6fw-mdWgzQ1Cs8SmLvE6swZqNqkUL42WEOAu01Dn5RGJR0VX7UCkUfWnaQIKkEFjFRqmCoaJyB5aYyWLNNj9B835SRWiqtJOK-aMkpyZwhRWCZ660kNS8bllDiZ5grashjulq2CudhmkISYKmUXkWS-BVBg19tqcqGXXVR8-f_8Poa9fJkIvgpBvwCuMCvcb4D8hxdZEcmsiCQFtJsMb6HmjVrrqwvXhm6M3Xj38dDWMk2L_XO2a5SCTcYCiSUQeDM670myegGHBUBERE7eeqH46Up_-6JnIeV-Al5v__lkPyS2AmSV27mXJFpktzpfuEUC5hX7cx-sfh6pI4g
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1da9UwGA7zeOONOL9WNzWKoII9tGmTphcimzimoIJ6ZDcS8rkNZ3t2eg7ov_dNmlOtHGG3zdtA34_keZrkCUJPqGSVzblOjWIGCArlKXde95aTirla08L5H_rvP7CjWfnumB5vofWdrdGB3UZq5--Tmi3Opz8vfr2Cgn8Zbm2o8vVL03nb2GmQLOf0CrpKSuDqfjNfOawrQHWH1UuPWlJGsiIepvtfL6PJKmj6DyP3ZH7edptg6b-7K_-arg5voOsRZ-L9PjG20ZZtbqLtWMkdfhblpp_fQt8O7FKmCia17wAFMYBYDKAQz6O2U9vg1mEYso2XfsZnDQ6SHd0LLPEfGWjcH4HBsjH4h-9PRrGT22h2-ObL66M0XrqQaqAOy7SqJeBtqXOmal0T7WhtCloAK-KKl3XBJJcF08CrHKsMoB2V59ZamjsrmaSquIMmDbhwB2GSmdxmThGjgcZxKVmtFYeat0QB9SsSlK69K-a9toYIC2wVcJLeTcJHQ8RoJOjAh2Cw9crY4UG7OBGx0ISySlKrJWdUl7o0smK5rR2MM64w1EInD30ARX_MdKhvsU9hZKJVyUmCHgcLr47R-O03J3LVdeLtx6-XMPr8aWT0NBq5FlJBy3jkAb7Jq26NLPdGllDjetS849Nt7ZVOEL_6yTx4hTfXKbi5-dHQ7Dv1W-oa2656G8IAnWYJuttn7ODZIoPAQqASVI1yeeT6cUtzdhrEyVng5PW9S3_6LroGILT2-_pItocmy8XK3gegt1QPQu3-BmwuUYA
  priority: 102
  providerName: Scholars Portal
Title Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/30893319
https://www.proquest.com/docview/2195360562
https://search.proquest.com/docview/2195269370
https://pubmed.ncbi.nlm.nih.gov/PMC6426199
https://doaj.org/article/beba5eca865c4c4da761e9f963f3d5e5
http://dx.doi.org/10.1371/journal.pone.0212785
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLe2cuGCGF_rGMUgJEAibfNhxzmu1cpA6pgGQ7ugyHbsUbEm1dL-_7znOGVBOyAuPsQvVvI-7N9Lnn8m5A2TPDWh0EGheAEJChOBsMh7K6KU20yz2OIH_fkpP7lIPl-yyx3C2r0wrmhfq8WwvF4Oy8VPV1u5WupRWyc2OptPucP92WiX7IKDtil6M_1CAHPu98jFaTjyJhmuqtIMHZ-5wNNq4jGeM4_8OreWI8fav52be6vrqr4LeP5dP3lrQZo9JA88kqRHzRPvkR1TPiJ7PlZr-s4TSr9_TH5MzFoGCpatXwD2KMBUCrCPrjx7U1XSylKYlAskd6aLkjpSjvoDlfQP0TNtNrlQWRZ0ieNJT2fyhFzMjr9NTwJ_rEKgITlYB2kmAVFLHXKV6SzSlmVFzGLIe4QSSRZzKWTMNWROlqcFqEmFoTGGhdZILpmKn5JeCdrcJzQaF6EZWxUVGhI1ISXPtBKgVhMpSO7iPgla7earhj0jd7_QUsg6GjXlaJjcG6ZPJmiCrSxyX7sL1c1V7j0gV0ZJZrQUnOlEJ4VMeWgyCzOJjQtmYJCXaMC82Ui6jeD8iMHcw9JERH3y2kkg_0WJBTZXclPX-acv3_9B6Ot5R-itF7IVuIKWflMDvBPyanUkDzuSEMW6072P7tZqpc4j_L_JEZ7Cna0L3t39atuNg2LRXGmqTSMTccCf4z551njsVrOt__dJ2vHljuq7PRCNjn7cR9_Bf9_5nNwH2JlhJV80PiS99c3GvABot1YDCOjLFFoxDbGdfRyQe5Pj07PzgftYAu08EQMX8L8B0qJUsA
link.rule.ids 230,315,730,783,787,867,888,2109,2228,12068,12235,12777,21400,24330,27936,27937,31731,31732,33278,33279,33385,33386,33756,33757,43322,43591,43612,43817,53804,53806,74073,74342,74363,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSMALYuNjhcEMQgIksjVx7DhPaEOMDtYhwTbtBVn-HBOQlKX9_7lL3G5BE-K1vlrtfZ999zMhL7gWhU-lTZwRDgoULhMZEPdWZoUIpeUs4IH-5ECMj_KPJ_wkHrg1sa1y4RNbR-1qi2fkWxne9wgM12-nvxN8NQpvV-MTGtfJjZxBrMZJ8d0PC08MtixEHJdjRboVpbM5rSu_2UKb4wvKl8JRi9q_9M2D6c-6uSrx_Lt_8lJA2r1L7sRMkm53ol8h13y1Sm5O4l35KlmJZtvQVxFb-vU98m3Hz3RiIIL9gLyPQsZKIQOk0wjkVFe0DhT8s0OcZ3pW0Rafo3lDNb3AfKbdvAvVlaO_cD8dkU3uk6Pd94fvxkl8YSGxUCfMkqLUkFxrmwpT2jKzgZeOcQYlkDQyL5nQUjNhoYgKonCQ2pg09d7zNHgtNDfsARlUwM01QrORS_0omMxZqNmk1qK0RoKB-8xAnceGJFkwWk07IA3V3qYVUIB0HFMoGBUFMyQ7KI0lLcJgtx_U56cqWpUy3mjurZaC29zmThci9WUApxKY4x422UBZqm6mdGnMapuDG-JFLrMhed5SIBRGhb02p3reNGrv8_F_EH390iN6GYlCDVphdZxvgP-EEFs9yvUeJRi07S2voeYtuNKoC9WHby608erlZ8tl3BT75ypfzzuaTEAqOhqSh53yLjnLRiBYENSQFD217rG-v1KdfW-RyEVbgJeP_v2zNsit8eFkX-3vHXx6TG5DylliF182WieD2fncP4G0bmaetrb7B_Y4S8Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLagSBMviI3LCoMZhARIZG2S-pIntAHVBmwgYKgvyPJ1TEBSlvb_c07iZguaEK_1iZWem88XH38m5AnTXPhU2sQZ7gCgMJnIgLy3MhM8FJblAT_oHx7x_ePJ2xmbxf6nOrZVrnJik6hdZfEb-SjD_R6Oy_UoxLaIj6-nL-e_E7xBCnda43UaV8k1ASgFfV7MOvAFcc15PDqXi3QULbUzr0q_09Cc423KF5amhsG_y9OD-c-qvqwI_buX8sLiNL1JbsSqku62brBOrvhyg6wdxn3zDbIeQ7imzyLP9PNb5NueX-jEwGr2A2pACtUrhWqQziOpU1XSKlDI1Q45n-lpSRuujvoF1fSc_5m2Z1-oLh39hfPpyHJymxxP33x5tZ_E2xYSC5hhkYhCQ6GtbcpNYYvMBla4nOUAh6SRkyLnWuqcWwBUgQsHZY5JU-89S4PXXDOT3yGDErS5SWg2dqkfB5M5C_hNas0LayQEu88MYL58SJKVotW8JdVQzc6aADDSakyhYVQ0zJDsoTU6WaTEbn6ozk5UjDBlvNHMWy05sxM7cVrw1BcBEkzIHfMwyTbaUrXnS7vAVrsMUhITE5kNyeNGAmkxSnSwE72sa3Xw4et_CH3-1BN6GoVCBV5hdTzrAP8J6bZ6kls9SQhu2xveRM9baaVW52EAT6688fLhR90wToq9dKWvlq1MxqEsHQ_J3dZ5O83mYzAsGGpIRM-te6rvj5Sn3xtWct6A8eLev19rm6xB2Kr3B0fv7pPrUH0W2NCXjbfIYHG29A-gwluYh03o_gGySE_8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beta-blockers+for+the+prevention+of+headache+in+adults%2C+a+systematic+review+and+meta-analysis&rft.jtitle=PloS+one&rft.au=Jackson%2C+Jeffrey+L&rft.au=Kuriyama%2C+Akira&rft.au=Kuwatsuka%2C+Yachiyo&rft.au=Nickoloff%2C+Sarah&rft.date=2019-03-20&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=14&rft.issue=3&rft.spage=e0212785&rft_id=info:doi/10.1371%2Fjournal.pone.0212785&rft.externalDocID=A579457482
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon